| http://www.w3.org/ns/prov#value | - oriconazole is not recommended concomitant use of erythromycin is not recommended exfoliative skin disorders have been reported rarely; some fatal cases reported in patients with serious underlying diseases, especially AIDS and malignancy; drug discontinuation recommended for persistent rash galactose intolerance, Lapp lactase deficiency, or glucose-galactose malabsorption; capsules contains lacto
|
